期刊文献+

我院2005~2007年致泌尿道感染的病原菌分布及耐药性变迁 被引量:2

Bacterial distribution and antimicrobial resistance in urinary system infection(2005-2007)
下载PDF
导出
摘要 目的探讨泌尿道感染的病原菌分布及耐药情况,为临床合理使用抗生素提供依据。方法对医院2005年1月至2007年12月间,住院及门诊泌尿系统患者尿培养分离出的488株病原菌进行鉴定和耐药分析。结果488株菌中革兰氏阴性杆菌290株,占59%,主要为大肠埃希菌、肺炎克雷伯菌;革兰氏阳性球菌119株,占24%,主要以肠球菌为主;真菌79株,占16%,主要为白假丝酵母菌。革兰氏阴性杆菌对亚胺培南的敏感率最高,但对其它抗菌药的敏感率下降趋势明显;革兰氏阳性球菌对万古霉素仍能保持较高的敏感率(>85%),但对其它抗菌药的耐药情况严重;真菌对两性霉素的敏感率最高。结论定期监测泌尿道感染病原菌的变迁及耐药情况的变化,对指导临床用药有重要的意义。 OBJECTIVE To study the distribution and resistance of pathogens in urinary tract infection, and propose rational use of antibiotics in clinic practice. METHODS The pathogens from the urine specimens were isolated and cultured from tbe patients in hospital from 2005 to 2007. The total 488 strains of pathogens were indentified and the drug resistance was analyzed. RESULTS In the 488 strains, there were 290 strains of gramnegative bacilli which accounted for 59 %, mainly included escherichia coli and klebsiella pneumoniae; 119 strains of gram-positive cocci (for 24% ), mainly is enterococci;79 strains of fungus (for 16% ), mainly is candida albicans. Imipenem was the most active antibiotics for gram-negative bacilli, vancomycin for gram-positive cocci, and amphotericin B for fungus. Pathogens antibiotics rate sensitive sustained downward trend. CONCLUSION A dynamic monitoring of drug susceptibility to pathogenic bacterium plays an important role in the clinic treatment.
出处 《海峡药学》 2008年第6期100-103,共4页 Strait Pharmaceutical Journal
关键词 泌尿道感染 菌群分布 耐药性 Urinary tract infection Flora distribution Antimicrobial resistance
  • 相关文献

参考文献14

二级参考文献62

  • 1林燕英,尹瑞明.我院泌尿道感染常见菌分析及细菌耐药性调查[J].泸州医学院学报,1995,18(3):205-207. 被引量:5
  • 2李家泰 李耘 王进.代表中国细菌耐药检测研究,2000~2001年度中国细菌耐药检测耐药研究革兰阴性杆菌耐药状况调查研究[J].现代感染病进展杂志,2002,4:1-13.
  • 3叶应妩 王毓三.全国临床检验操作规程[S].[S].南京:东南大学出版社,1997.474-486.
  • 4Lamb DC,Kelly DE,White TC,et al.The R467K amino acid substitution in Candida albicans sterol 14alpha-demethylase causes drug resistance through reduced affinity[J].Antimicrob Agents Chemother,2000,44(1)∶63-67.
  • 5Alexander BD,Perfect JR.Antifungal resistance trends towards the year 2000[J].Drugs,1997,54(5)∶657-678.
  • 6Marichal P,Koymans L,Willemsens S,et al.Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p,Cyp51p) to azole resistance in Candida albicans[J].Microbiology,1999,145(Pt 10)∶2701-2713.
  • 7White TC.The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans[J].Antimicrob Agents Chemother,1997,41(7)∶1488-1494.
  • 8Franz R,Kelly SL,Lamb DC,et al.Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains[J].Antimicrob Agents Chemother,1998,42(12)∶3065-3072.
  • 9Sanglard D,Ischer F,Koymans L,et al.Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents[J].Antimicrob Agents Chemother,1998,42(2)∶241-253.
  • 10White TC,Marr KA,Bowden RA.Clinical,cellular,and molecular factors that contribute to antifungal drug resistance[J].Clin Microbiol Rev,1998,11(2)∶382-402.

共引文献177

同被引文献9

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部